Biospectal
Lausanne
About Biospectal
Biospectal is the remote patient monitoring and biosensing software company, developed the OptiBP smartphone app and data platform to empower people worldwide with a medical-grade device integrated directly into their smartphone for instantaneous blood pressure measurement and monitoring, anytime and anywhere. The app runs on a typical smartphone and uses the built-in camera to record and measure a user’s blood flow via their fingertip quickly and easily. A measurement is rendered in approximately 20 seconds ’ half the time of a typical blood pressure cuff. The company’s proprietary algorithms and optical signal capture methods then transform the captured data into blood pressure values. The Biospectal OptiBP for Android public beta is available now in the US, UK, France, Germany, Spain and Switzerland.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $5.6M
- Funding stage: Seed
- Last round: Seed (Jul 2021)
- Website: biospectal.com
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical, Medical Device, Software
Social Profiles
Canonical: https://fsome.com/organization/biospectal-47296 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.